首页> 外文期刊>Clinical lipidology. >An update on statin alternatives and adjuncts
【24h】

An update on statin alternatives and adjuncts

机译:他汀类药物替代品和药物的更新

获取原文
       

摘要

LDL cholesterol is the primary target of therapy to lower cardiovascular risk. Statins are medications of first choice to lower LDL cholesterol, but cannot be tolerated in up to 10% of individuals. Intermittent dosing strategies for statins can help reduce muscle symptoms in some patients. A Mediterranean-type diet supplemented with plant stanols and sterols, fiber and fish oils can help achieve cholesterol goals and reduce cardiovascular events. Caution may be needed when using supplements, such as red yeast rice, because of the concern regarding contaminants. Other lipid-lowering medications, such as intestinal agents, niacin and fibrates, can be used as alternative strategies in patients who cannot tolerate statins or in combination with low-dose statins to achieve lipid goals and reduce cardiovascular risk.
机译:LDL胆固醇是降低心血管疾病风险的主要治疗目标。他汀类药物是降低LDL胆固醇的首选药物,但最多10%的患者不能耐受。他汀类药物的间歇给药策略可以帮助减轻某些患者的肌肉症状。一种地中海式饮食,辅以植物甾烷醇和固醇,纤维和鱼油,可以帮助达到胆固醇目标并减少心血管事件。由于担心污染物,使用补充剂(如红曲米)时可能需要小心。对于不能耐受他汀类药物或与低剂量他汀类药物联合使用以达到血脂目标和降低心血管疾病风险的患者,其他降脂药物(例如肠道药物,烟酸和贝特类药物)可用作替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号